Company / Total Assets
ClearPoint Neuro, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$97.7M
FY2025
5-year range
$39.2M / $97.7M
FY2021-FY2025
Trend
+149.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets returned to growth in FY2025 after 3 years of decline, reaching $98M.
Based on SEC 10-K filings.
$98M in FY2025 with a 5-year CAGR of +27.1%.
Improved from $43M to $98M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +20.8%
- 5-Year CAGR
- +27.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +27.1%, indicating consistent growth.
- In FY2025, total assets increased 149.4% year-over-year.
- Lowest total assets in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.71 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $97.7M | +149.4% |
| FY2024 | $39.2M | -8.1% |
| FY2023 | $42.7M | -23.1% |
| FY2022 | $55.5M | -15.4% |
| FY2021 | $65.6M | +122.2% |
| FY2020 | $29.5M | +147.5% |
| FY2019 | $11.9M | +51.8% |
| FY2018 | $7.9M | -43.5% |
| FY2017 | $13.9M | +87.8% |
| FY2016 | $7.4M | -25.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026